Calculateur du score d’alerte précoce modifié (Wheeler 2013)

État

clinical-review-pending

Version de la méthode

Wheeler et al. 2013 PLOS ONE Table 1 MEWS arithmetic v1 (maximum 14): systolic blood pressure scores <70=3, 70–80=2, 81–100=1, 101–199=0, ≥200=2; heart rate scores <40=2, 40–50=1, 51–100=0, 101–110=1, 111–129=2, ≥130=3; respiratory rate scores <9=2, 9–14=0, 15–20=1, 21–29=2, ≥30=3; axillary temperature °C scores <35=2, 35–38.4=0, ≥38.5=2; directly recorded AVPU scores Alert=0, Voice=1, Pain=2, Unresponsive=3. Total is the sum of all five components; no partial score, imputation, carry-forward, default-normal rule, cutoff, or category is supplied

Population

Adults in a medical-admission context for whom the exact Wheeler et al. 2013 Table 1 version and its source population are independently established as applicable. Systolic blood pressure, heart rate, respiratory rate, source-method axillary Celsius temperature, and directly recorded AVPU must form one complete contemporaneous observation set with verified units, measurement identities, and source values.

Limites et exclusions

Any MEWS variant other than Wheeler et al. 2013 Table 1; an original, standard, or universal MEWS claim; pediatric, obstetric, trauma, surgical, intensive-care, or prehospital extrapolation without separate validation; or substitution of a different temperature site or scoring table. · Missing, non-contemporaneous, inferred, imputed, carried-forward, worst-over-time, or default-normal variables; a partial score; conversion from GCS to AVPU; inferred AVPU from sedation or another mental-status description; or an untestable response silently coded as Alert. · Any cutoff, trigger, risk band, category, prognostic certainty, reassurance from a low score, escalation command, monitoring protocol, disposition, diagnosis, management, treatment, or claim of local validation. The selected source reported weak discrimination in its cohort and called for local validation and impact assessment.

• https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0059830
• https://doi.org/10.1371/journal.pone.0059830.t001
• https://doi.org/10.1371/journal.pone.0059830
• https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0091623
• https://pubmed.ncbi.nlm.nih.gov/11588210/

Outil importé de la bibliothèque PharmaTek de MDose. Aucune date de révision clinique indépendante n’est documentée dans cette version.

Bibliothèque source

PharmaTek · MDose

Version importée

4b66536936ed

État de publication

Révision clinique en cours